Artificial Intelligence in Drug Discovery Market to See Stunning Growth: USD 16.21 billion with a CAGR of 29.8% by 2032 | Key Players- Benevolent AI, Berg Health, BIOAGE

The artificial intelligence in drug discovery market size is projected to be valued at USD 1.55 billion in 2023 and is expected to rise to USD 16.21 billion by 2032. The market is expected to register a CAGR of 29.8% during the forecast period from 2024 to 2032.

𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐩𝐫𝐨𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐭𝐡𝐞 𝐝𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐚𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐢𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐝𝐫𝐮𝐠 𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

• The industry can identify hit and lead compounds, optimize medicine structure design, and enable speedier validation of medicinal targets, all of which are expected to fuel demand for AI in drug discovery.
• Demand for the company was spurred by the difficulties associated with data digitalization, such as analyzing, obtaining, and using information to address complex medical issues in the pharmaceutical industry.
• The widespread use of AI in several areas of pharmaceutical discovery, such as polypharmacology, drug screening, chemical synthesis, drug repurposing, and drug design, is expected to drive market expansion significantly.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐀 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐓𝐨 𝐆𝐚𝐢𝐧 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market/request-for-sample

𝐖𝐡𝐚𝐭 𝐈𝐬 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲?

In drug research, artificial intelligence (AI) makes use of sophisticated algorithms to evaluate large datasets, forecast chemical interactions, and create new compounds with therapeutic promise. Artificial intelligence (AI) speeds up the medication development process by optimizing compound selection and cutting expenses through machine learning and data mining approaches. It improves lead optimization, toxicity prediction, and target discovery, transforming pharmaceutical research and accelerating the delivery of life-saving drugs.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:

Because there are so many companies in the industry, it is expected to be both competitive and fragmented. Some of the leading companies in the artificial intelligence in drug discovery market:
• Atomwise
• Benevolent AI
• Berg Health
• BIOAGE
• BioSymetrics
• Cloud Pharmaceuticals
• Cyclica
• Deep Genomics
• DeepMind
• Envisagenics
• Euretos
• Exscientia
• GNS Healthcare
• IBM Corporation
• Insilico Medicine
• Insitro

𝐂𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐁𝐞𝐥𝐨𝐰 𝐋𝐢𝐧𝐤 𝐭𝐨 𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/buy/628/2

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

• Increasing R&D Costs and Time: The high costs and lengthy timelines associated with traditional drug discovery methods are driving the adoption of AI to accelerate and economize the process.
• Advancements in AI and Machine Learning: Continuous improvements in AI algorithms, machine learning models, and computational power are enhancing the capabilities of AI in drug discovery.
• Growing Volume of Biomedical Data: The vast amount of data generated from genomics, proteomics, and other omics technologies provides a rich resource for AI to analyze and derive meaningful insights.
• Collaborations and Partnerships: Increasing collaborations between pharmaceutical companies, AI technology providers, and academic institutions are fostering innovation and accelerating AI adoption in drug discovery.
• Regulatory Support: Growing regulatory acceptance of AI-driven approaches in drug development is facilitating their integration into the drug discovery pipeline.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

• North America (U.S., Canada)
• Europe (France, Germany, UK)
• Asia Pacific (Japan, China, Australia)
• Latin America
• Middle East & Africa

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/ai-in-drug-discovery-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐁𝐫𝐞𝐚𝐤𝐝𝐨𝐰𝐧:

Artificial intelligence in drug discovery market is mainly segmented on the basis of application, technology, therapeutic area, offering, and region. Based on the application analysis, The medication optimization and repurposing category is predicted to generate the most revenue due to its increased use in healing target discovery and forecast of new medicinal uses.

By Application
• Drug optimization & repurposing
• Preclinical testing
• Others

By Therapeutic Area
• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Infectious Disease
• Others

By Offering
• Software
• Services

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞-𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏𝐌𝐑'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Research Antibodies Market: https://www.polarismarketresearch.com/industry-analysis/research-antibodies-market

Intravenous Iron Drugs Market: https://www.polarismarketresearch.com/industry-analysis/intravenous-iron-drugs-market

Hpv Testing And Pap Test Market: https://www.polarismarketresearch.com/industry-analysis/hpv-testing-and-pap-test-market

Oligonucleotide Synthesis Market: https://www.polarismarketresearch.com/industry-analysis/oligonucleotide-synthesis-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.